Restore FSD Pharma $HUGE Be Strong Fellow Longs !There is over 1,000,000 shares short thats alot more shares then the average investor holds.
FSD Pharma SHORTSELLER INFO [img]https://www.thebalance.com/thmb/_aVZ1EpKq2JbmvnxeZ7_tTMFC4o=/1333x1000/smart/filters:no_upscale()/the-basics-of-shorting-stock-356327-v2-5bc4c22346e0fb0026b436d3.png[/img]
Sure it maybe is only 2-3% short vs OS Outstanding shares but that isn't insignificant to say the least the average normal person doesn't hold that many shares LOL
I only have 44,340 shares all together with my family.
So if someone is shorting the stock by millions of shares , you really think they aren't making money in the process?
They are purposefully making up stories most likely and focusing on bad performance
HEDGE FUNDS Love to make up stories sometimes , ( not all hedgefunds) but some to scare away retail investors this his how they make money https://www.investopedia.com/articles/analyst/030102.asp
https://en.wikipedia.org/wiki/Short_and_distort
So if you guys are gullable and think these are normal people talking nonsense wake up and smell the coffee there is a reason why YAHOO and STOCKHOUSE have a fleet of shortseller bashers working together
They NEVER focus on positive developments at FSD Pharma , Sure there were alot of negative things that happened but as soon as they smelled any sort of growth or positivity they start attaking again trying to scare you guys away.
Im also in the RED and averaged down many times. All stocks carry risks , but not all stocks that AD and his investment bank touched flopped
Gratomic was a success more or less it's stable and isn't pump and dumped,
High tide is a success , i wish i grabbed more before but sold it and missed the boat.
They say AD has 90% Failure rate but yet they don't mention the companies which failed
Sure FSD Went down under Raza Bokhari's Leadership, PUMP turned into a delivery service but is still making roughly $10,000,000 a year and wont be bankrupt any time soon.
$REZN is a new company that does HASH it just got listed , IF USA Legalizses federally i expect PUMP and REZN to penetrate that market Cannabis industry might be 6 years old in canada but in USA it's just starting
Anyways back to FSD Pharma LUCID Deal is the real deal , UHN is credible.
Ignore the basher shortsellers I expect more and more of them each time FSD Pharma grows and does good moves (hopefully)
Always ask your financial advisor for advice, they might be cautious right now since there is a BIG HUGE RESET happening, but if there are good developments by the time the financial advisor hears about it maybe it will be higher then $2. Just my own opinion.
It's stressful reading negative comments all the time but rememeber why that's so.
They want stock to go down so the shortsellers can pocket the difference.
So yes shortsellers are in theory also "investors" if the stock goes up instead of down , they are forced to buy it as a higher price point.
Thanks guys and have a nice day ! BE STRONG
https://www.uhn.ca/Krembil
Lucid Psycheceuticals in pact with UHN to develop neurodegenerative therapeutics
Lucid Psycheceuticals inked a world-wide license agreement with Toronto’s University Health Network (UHN), Canada’s top research hospital, granting Lucid exclusive rights to novel compounds for therapeutic applications in neurodegenerative disorders.
UHN includes the Toronto General and Toronto Western hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and The Michener Institute of Education at UHN.
The newly licensed technologies will be used by Lucid to develop small molecule therapeutics addressing unmet therapeutic needs in neurodegenerative disorders, such as multiple sclerosis, where demyelination and neurodegeneration are key aspects of disease progression.
Closely-held Lucid was founded with a mission to develop novel therapeutics for “Total Brain Health.” This expansion of its drug development pipeline is complementary and synergistic with its core values and scientific/drug discovery efforts.
“Collaborations such as this one are a great example of how commercialization efforts can help translate key discoveries faster to benefit patients with unmet clinical needs sooner and create a healthier world,” Dr. Brad Wouters, EVP of science and research at UHN, said in a statement.
Dr. Lakshmi Kotra, a co-founder and CEO of Lucid, said the license agreement is a significant step in expanding a pipeline of molecules targeting some of the most challenging brain disorders, potentially helping millions of patients suffering from mental health challenges and neurodegenerative disorders in the future.
LUCID UHN